Implantica announces positive feedback received from U.S. FDA of the RefluxStop PMA Module 2 submission
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop ...
Le Lézard2h
Implantica announces positive feedback received from U.S. FDA of the RefluxStoptm PMA Module 2 submission
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStoptm for the treatment of acid reflux, a treatment field ...
Implantica announces positive feedback received from U.S. FDA of the RefluxStop™ PMA Module 2 submission
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field ...
Illuccix® Approved in the United Kingdom
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
Healthline19h
Federal Health Agencies Ordered to Restore Public Facing Webpages, Data
A federal judge ordered federal health agencies to restore public-facing media, which was deleted following President Trump's ...
Earnings call transcript: Neola Medical Q4 2024 focuses on innovation and expansion
AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...
Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStop™
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field ...
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...
STAT2d
FDA cites Indian ingredients supplier for deleting records
One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...
Bakery company on recall involving Dunkin': "All donuts are completely safe to eat"
Indiana-based firm FGF, LLC, said that its nationwide FDA recall of 60 baked goods over Listeria risk, including certain ...
Hims & Hers Health down as Super Bowl ad draws controversy
An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.